JUPITER NEUROSCIENCES, INC.
For the period ended Jun 30, 2025. Filed Aug 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 19, 2025
JUNS$2.200.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Changes in Stockholders’ Deficit
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount · in Capital · Deficit · (Deficit) | ||||||
| December 31, 2024 | 33,103,860 | $3,310 | $30,190,827 | - | $(26,022,129) | $4,172,008 |
| Stock-based compensation | - | - | 421,454 | - | 421,454 | |
| Net loss | - | - | - | - | (1,528,867) | (1,528,867) |
| March 31, 2025 | 33,103,860 | $3,310 | $30,612,281 | - | $(27,550,996) | $3,064,595 |
| Stock-based compensation | - | - | 462,488 | - | 462,488 | |
| Shares issued for services rendered | 103,186 | 10 | 65,990 | - | 66,000 | |
| Shares issued for vested restricted stock units | 1,626,037 | 163 | (163) | - | - | |
| Net loss | - | - | - | - | (2,252,965) | (2,252,965) |
| June 30, 2025 | 34,833,083 | $3,483 | $31,140,596 | - | $(29,803,961) | $1,340,118 |
| Additional · Receivables for Sale of · Total Stockholders’ | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Paid · Common · Accumulated · Equity | |||||||
| Shares · Amount · in Capital · Stock · Deficit · (Deficit) | |||||||
| December 31, 2023 | 26,526,405 | $2,652 | $17,778,498 | $ | - | $(23,582,504) | $(5,801,354) |
| Stock-based compensation | - | - | 355,317 | - | - | 355,317 | |
| Issuance of restricted stock and stock options for accrued compensation | - | - | 60,000 | - | - | 60,000 | |
| Net loss | - | - | - | - | (634,100) | (634,100) | |
| March 31, 2024 | 26,526,405 | $2,652 | $18,193,815 | $ | - | $(24,216,604) | $(6,020,137) |
| Stock-based compensation | - | - | 276,983 | - | - | 276,983 | |
| Shares issued for vesting of restricted stock | 3,487,500 | 349 | (349) | - | - | - | |
| Sale of common stock, net of receivables of $75,000 | 112,500 | 11 | 149,989 | (75,000) | - | 75,000 | |
| Reconciling shares due to forward stock split | 8 | - | - | - | - | - | |
| Net income | - | - | - | - | 313,123 | 313,123 | |
| June 30, 2024 | 30,126,413 | $3,012 | $18,620,438 | $(75,000) | $(23,903,481) | $(5,355,031) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.